Emami Ltd (EMAMILTD) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Emami's core domestic business achieved robust growth of 11% in Q4, with a volume growth of around 7%. This growth was driven by strong performance across various brands and categories.
- Navratna and Dermicool range experienced a 16% growth, while Boro Plus range saw a significant 27% increase.
- Healthcare range showed a healthy 13% growth, and the pain management segment grew by 1%.
- The newly repositioned Smart and Handsome brand achieved a 7% growth, while Kesh King experienced flattish growth.
- Organized channels, including modern trade, E-com, and institutional sales, continued to perform strongly, contributing around 28% to domestic revenue in FY25.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.